 Surreptitious ingestion long-acting vitamin brodifacoum clinical metabolic studies cases vitamin metabolism patients factitious purpura due ingestion patients bleeding disorders due deficiency vitamin K-dependent blood clotting proteins refractory standard doses fresh frozen plasma large doses vitamin Metabolic studies blockade vitamin utilization consistent presence vitamin antagonist patients use anticoagulants Warfarin assays negative factitious purpura patient due surreptitious ingestion brodifacoum potent second generation long-acting vitamin antagonist rodenticide coagulopathies long-term therapy large doses vitamin serum elimination half-time brodifacoum days patients anticoagulant effect long duration chronic vitamin treatment availability new rodenticides factitious purpura due surreptitious ingestion potent vitamin new problem warfarin important implications diagnosis treatment